IL151335A0 - 103p2d6: tissue specific protein highly expressed in various cancers - Google Patents

103p2d6: tissue specific protein highly expressed in various cancers

Info

Publication number
IL151335A0
IL151335A0 IL15133501A IL15133501A IL151335A0 IL 151335 A0 IL151335 A0 IL 151335A0 IL 15133501 A IL15133501 A IL 15133501A IL 15133501 A IL15133501 A IL 15133501A IL 151335 A0 IL151335 A0 IL 151335A0
Authority
IL
Israel
Prior art keywords
highly expressed
expressed
specific protein
tissue specific
various cancers
Prior art date
Application number
IL15133501A
Other languages
English (en)
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of IL151335A0 publication Critical patent/IL151335A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15133501A 2000-02-24 2001-02-26 103p2d6: tissue specific protein highly expressed in various cancers IL151335A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18455800P 2000-02-24 2000-02-24
US21885600P 2000-07-13 2000-07-13
PCT/US2001/005996 WO2001062925A2 (fr) 2000-02-24 2001-02-26 103p2d6: proteine specifique de certains tissus, fortement exprimee dans divers cancers

Publications (1)

Publication Number Publication Date
IL151335A0 true IL151335A0 (en) 2003-04-10

Family

ID=26880247

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15133501A IL151335A0 (en) 2000-02-24 2001-02-26 103p2d6: tissue specific protein highly expressed in various cancers
IL151335A IL151335A (en) 2000-02-24 2002-08-19 103p2d6: tissue specific protein highly expressed in various cancers

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151335A IL151335A (en) 2000-02-24 2002-08-19 103p2d6: tissue specific protein highly expressed in various cancers

Country Status (7)

Country Link
EP (1) EP1257644B1 (fr)
AT (1) ATE373711T1 (fr)
AU (2) AU2001241742B8 (fr)
CA (1) CA2400443A1 (fr)
DE (1) DE60130541T2 (fr)
IL (2) IL151335A0 (fr)
WO (1) WO2001062925A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383800A1 (fr) * 1999-09-03 2001-03-15 Human Genome Sciences Inc. 52 proteines humaines secretees
US7534417B2 (en) 2000-02-24 2009-05-19 Agensys, Inc. 103P2D6: tissue specific protein highly expressed in various cancers
IL160651A0 (en) 2001-08-31 2004-07-25 Agensys Inc Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same
CA3066894A1 (fr) * 2017-06-22 2018-12-27 Institut Gustave Roussy Proteine retrovirale endogene humaine
CA3165251A1 (fr) * 2020-01-21 2021-07-29 Jeffrey Schlom Epitopes immunogenes humains de retrovirus endogenes humains (herv) hemo et hhla2
DE102020125457A1 (de) * 2020-09-29 2022-03-31 Immatics Biotechnologies Gmbh Amidierte Peptide und ihre deamidierten Gegenstücke, die durch HLA-A*02-Moleküle präsentiert werden, zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001519666A (ja) * 1997-04-10 2001-10-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌発現配列タグ（ｓＥＳＴｓ）
EP1074617A3 (fr) * 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
CA2383800A1 (fr) * 1999-09-03 2001-03-15 Human Genome Sciences Inc. 52 proteines humaines secretees

Also Published As

Publication number Publication date
EP1257644B1 (fr) 2007-09-19
EP1257644A2 (fr) 2002-11-20
DE60130541T2 (de) 2008-06-19
AU2001241742B2 (en) 2006-04-06
IL151335A (en) 2009-09-01
AU4174201A (en) 2001-09-03
WO2001062925A3 (fr) 2002-03-28
WO2001062925A2 (fr) 2001-08-30
CA2400443A1 (fr) 2001-08-30
ATE373711T1 (de) 2007-10-15
AU2001241742B8 (en) 2006-05-11
DE60130541D1 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
IL147902A0 (en) C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
MXPA03001634A (es) Polipeptido tumoral cripto.
WO2004113571A3 (fr) Genes specifiques de la prostate et leur utilisation comme cibles dans le traitement et le diagnostic du cancer de la prostate
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
EP1706423B8 (fr) Anticorps therapeutiques et diagnostiques anti-hsp 70
IL146125A0 (en) Novel quinones as disease therapies
IL151335A (en) 103p2d6: tissue specific protein highly expressed in various cancers
WO2003070889A3 (fr) Genes specifiques de la prostate et leur utilisation dans la conception ou la therapie
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
EP2365081A3 (fr) Protéine à treize segments transmembranaires exprimée dans le cancer de la prostate
SG148035A1 (en) Gene products differentially expressed in cancerous breast cells and their methods of use
WO2001059110A3 (fr) 34p3d7: proteine specifique aux tissus hautement exprimes dans le cancer de la prostate
WO2001055391A3 (fr) 84p2a9: proteine specifique de la prostate et du testicule fortement exprimee dans le cancer de la prostate
WO2001059115A3 (fr) Le 83p5g4: proteine specifique de tissus fortement exprime dans le cancer de la prostate
WO2002002772A3 (fr) Marqueur tumoral associe a la matrice extracellulaire
WO2001079557A3 (fr) Proteine de fixation gtp pour le traitement et la detection du cancer
WO2001090157A8 (fr) 98p7c3: proteine a homeodomaine fortement exprimee dans divers cancers
WO2003020954A3 (fr) Acide nucleique et proteine correspondante appelee 205p1b5 utilises dans le traitement et la detection du cancer
WO2001098339A3 (fr) Compositions et procedes de traitement et de diagnostic du cancer du sein
WO2004078123A3 (fr) Antigenes precoces du cancer de la prostate (epca), sequences polynucleotidiques codant ces antigenes, et leur utilisation
AU2003229876A1 (en) Tumour associated antigens
WO2000061610A3 (fr) Nouveau gene specifique de la prostate exprime dans le cancer de la prostate
WO2003042700A3 (fr) Polypeptide associe au cancer du sein
AU2002243918A1 (en) Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor